BioInovio – Redox-Electronic Biology for Health and Longevity
Problem
Modern medicine overlooks the electronic properties of biomolecules, focusing on structural and molecular layers while ignoring the redox-electronic level that governs interaction, recognition, and biological function.
Solution
BioInovio applies fundamental redox-electronic parameters (EIIP, AQVN) to diagnose and rebalance electronic dysfunction in aging, disease, and health decline. We integrate this with AI-driven decision tools to optimize therapy and prevention.
What Makes Us Unique
We are the first to apply electronic-level descriptors of life in real-world diagnostics and personalized medicine. Our platform uses electron-based informatics to reveal invisible dysfunctions before they manifest clinically.
Stage
Prototype-ready. Platform architecture established. Scientific validation based on 500+ peer-reviewed publications. AI integration under development.
Goals
Establish partnerships with longevity clinics and biotech/AI companies. Raise funding for pilot validation studies. Launch MVP in redox diagnostics and personalized supplement programs.
Contact
electronicbiology.org | contact@bioinovio.com | Veljko Veljkovic